Orthocell (ASX:OCC)
ASX announcement history & article coverage
Transparent by design.
Announcments by Orthocell (ASX:OCC) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appendix 4G
Corporate Governance Statement
Appendix 4E & Annual Report
Orthocell reports record 45% revenue growth to AUD 13.2M, expands US and international sales, plans manufacturing expansion
Orthocell Canaccord Genuity Conference Live Webcast
Orthocell to Present at Canaccord Growth Conference
Change of Registered Office & Principal Place of Business
Appendix 3Y - John Van Der Wielen
Application for quotation of securities - OCC
Appendix 3Y x 4
Application for quotation of securities - OCC
Notification regarding unquoted securities - OCC
Notification regarding unquoted securities - OCC
Option Terms and Conditions
Proposed issue of securities - OCC
Notification of cessation of securities - OCC
Q4 FY26 ASX Investor Presentation
Orthocell delivers record FY26 revenue with strong US Remplir growth and solid cash position
Quarterly Activity Report & Appendix 4C
Orthocell posts record FY2026 revenue of AUD 13.2M with strong US and international growth, robust cash position supports expansion
Orthocell Investor Webinar Details
Orthocell Appoints Thailand Distributor for Remplir
Orthocell appoints MediTime as exclusive Remplir distributor in Thailand's US$84 million nerve repair market
Clinical Outcomes See Expanded Use of Remplir in the Ukraine